Six of the 10 remaining genes, despite not being listed, were genes for which literature search supported undeniable oncogenic properties (STIM2, ARHGAP24, KLF12, KMT2C, CCDC88C and DOCK11), and 4 genes were—to our knowledge—not previously reported in cancer, yet may include new candidate drivers. This evidence concerns the gene KLF12 and cancer.